Pfizer revenue decreased from $53.6 billion in 2018 to $51.8 billion in 2019, a 3.5% decrease.

Annual Revenue ($)

Pfizer revenue was $51.75 b in FY, 2019

Quarterly Revenue ($)

FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019
Revenue$48.85 b$52.82 b$52.55 b$53.65 b$51.75 b
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020
Revenue$13.01 b$13.15 b$13.05 b$12.78 b$12.90 b$13.17 b$12.91 b$13.47 b$13.30 b$13.12 b$13.26 b$12.68 b$12.03 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Pfizer revenue breakdown by business segment: 45.2% from Essential Health and 54.8% from Innovative Health

Pfizer revenue breakdown by geographic segment: 44.4% from United States, 19.9% from Developed Europe, 12.9% from Developed Rest of World and 22.8% from Emerging Markets

FY, 2017FY, 2016FY, 2015
Essential Health21.12 b23.63 b22.09 b
Innovative Health31.42 b29.20 b26.76 b
FY, 2017FY, 2016FY, 2015
United States26.03 b26.37 b21.70 b
Developed Europe8.51 b9.31 b9.71 b
Developed Rest of World6.61 b6.73 b6.30 b
Emerging Markets11.40 b10.42 b11.14 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.